Stepping up to an 18-inch form factor, the Alienware Area-51 18 brings a larger canvas and meaningfully more GPU muscle. The display runs at 300Hz with 500 nits of brightness, 100% DCI-P3, G-SYNC, and ...

Dell has launched three new Alienware gaming monitors, led by a brighter and faster 34-inch QD-OLED model priced at $799.99.

Alienware’s latest 34-inch ultrawide gaming monitor is far brighter than before, and it can finally handle text without ...

The Alienware AW3426DW combines just-the-basics design with an excellent five-layer tandem QD-OLED panel to deliver great ...

The Legion 9i Gen 10 is the top dog in Lenovo's gaming laptop stable. It goes big, and it goes fast, packing in top-end CPU ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Arthur Gies Arthur Gies is an editor for Wirecutter's tech coverage. He's ...

AWCC* is an unofficial alternative to Alienware Command Centre of Windows for the Alienware Series Device on Linux, supporting almost all features that the Windows version supports, including custom ...

First-quarter sales guidance was “in the range of $490 million to $510 million” (Senior VP & CFO Taylor Luebke) vs. $495.449 million (Street revenue estimate for Q1 FY2027). Luebke guided to “adjusted ...

A Merck & Co. researcher at work. Merck will partner with Protillion Biosciences to discover multiple new therapy candidates, through a collaboration that could generate up to $510 million in ...

MSD has formed a partnership with Protillion Biosciences, worth upwards of $510 million, that will focus on using the AI specialist's 'lab-in-the-loop' platform to discover multiple new therapeutics.

The next stop on biopharma’s AI train is Merck, which is bringing on California’s Protillion Biosciences to combine large-scale data generation and AI design to advance a suite of novel biologic ...

AI drug design specialist Protillion Biosciences has inked a $510 million biobucks collaboration and license agreement with Merck & Co., bringing together Protillion’s platform and Merck’s drug ...